+86 137 2013 4139
CAS: | 288383-20-0 | Cat No: | JKN00574 | Purity: | 98% |
Note: All products of the company are for scientific research only, and do not provide products and services for any individual
Product Description
CAS | 288383-20-0 | Cat No | JKN00574 | |
Name | Cediranib | |||
Synonyms | Cediranib | |||
Smiles | FC1=C(C([H])=C([H])C2=C1C([H])=C(C([H])([H])[H])N2[H])OC1C2=C([H])C(=C(C([H])=C2N=C([H])N=1)OC([H])([H])C([H])([H])C([H])([H])N1C([H])([H])C([H])([H])C([H])([H])C1([H])[H])OC([H])([H])[H] | |||
Chemical Name | 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline | |||
Formula | C25H27FN4O3 | MWt | 450.51 | |
Purity | 98% | Storage | Store at 4--8℃ | |
Description | Cediranib (also called NSC732208; AZD2171,tentative trade name Recenti),an indole ether quinazoline derivative, is a potent and oral VEGFR (vascular endothelial growth factor receptors) inhibitor with potential antitumor activity. |
Product Documents
Menu
Contact Us
Tel: +86 137 2013 4139
E-mail: orders@jknbiochem.com
Add.:Room 2120, Office Building 2, No.1 Baisha Fifth Road, Hongshan District, Wuhan City, Hubei Province, China
Get In Touch
Get In Touch